Market
Will Xpert MTB/RIF Ultra be adopted in at least 50% of WHO member countries by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
WHO reports or announcements regarding the adoption rates of the test
Story
WHO Prequalifies First TB Diagnostic Test: Xpert MTB/RIF Ultra, Addressing Over a Million Deaths Annually
Dec 6, 2024, 09:36 PM
The World Health Organization (WHO) has announced the prequalification of the Xpert MTB/RIF Ultra test, marking it as the first diagnostic test for tuberculosis (TB) to meet WHO standards. This development is part of ongoing efforts to combat TB, which is responsible for over a million deaths annually. The endorsement of this rapid molecular test is seen as a significant step towards improving the accuracy and speed of TB diagnosis, particularly for drug-resistant strains. WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of early detection in addressing this global health crisis.
View original story
Similar markets
21 to 30 • 25%
More than 30 • 25%
10 to 20 • 25%
Less than 10 • 25%
High adoption (75%+ countries) • 25%
Minimal adoption (<25% countries) • 25%
Low adoption (25-49% countries) • 25%
Moderate adoption (50-74% countries) • 25%
More than 60% • 25%
40% to 60% • 25%
Less than 20% • 25%
20% to 40% • 25%
More than 60% • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 6 Countries • 25%
4-6 Countries • 25%
1-3 Countries • 25%
None • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
11-15 countries • 25%
16 or more countries • 25%
6-10 countries • 25%
1-5 countries • 25%